Rigel Pharmaceuticals Options See Significant Rise in Implied Volatility

Rigel Pharmaceuticals Sees Notable Options Activity

Recently, Rigel Pharmaceuticals, Inc. (RIGL) has drawn attention from investors due to significant movements in its options market. In particular, the March 20, 2026 $10.00 Call option displayed some of the highest implied volatility among all equity options today.

Understanding Implied Volatility

Implied volatility reflects the market’s expectations for future price fluctuations. When options show elevated implied volatility, it often signals that traders anticipate substantial price swings—either upward or downward—in the underlying stock. This could be in response to an upcoming event that might trigger a sharp rally or a steep decline. However, implied volatility is just one factor to consider when developing an options trading strategy.

Analyst Insights on Rigel Pharmaceuticals

The options market suggests that traders are bracing for a major move in Rigel Pharmaceuticals shares. But what do analysts say about the company’s fundamentals? Rigel Pharmaceuticals currently holds a Zacks Rank #3 (Hold) within the Medical - Drugs sector, which places it in the lower 44% of the Zacks Industry Rank. Over the past two months, one analyst has raised their earnings estimate for the current quarter, while no analysts have lowered theirs. As a result, the Zacks Consensus Estimate for this quarter has increased from 69 cents per share to 90 cents.

Given these analyst perspectives, the surge in implied volatility may indicate a potential trading opportunity. Many experienced options traders seek out contracts with high implied volatility to sell premium, aiming to benefit from time decay. Their strategy is that, by expiration, the stock’s actual movement will be less dramatic than the market anticipated.

Interested in Options Trading?

Discover the straightforward yet powerful strategy that Zacks Executive VP Kevin Matras has used to achieve recent double- and triple-digit gains. These trades not only offer strong profit potential but can also help manage risk.

Additional Resources

• Get the most recent stock picks from Zacks Investment Research. Download the “7 Best Stocks for the Next 30 Days” for free.
• For a complimentary analysis of Rigel Pharmaceuticals, Inc. (RIGL), visit Zacks Investment Research for a free stock analysis report.